Building Bridges Between Academia and Big Pharma

​How does one of the world's leading pharmaceutical companies innovate and find new external opportunities? How can academics benefit from it?

​Join us to hear firsthand from Johnson & Johnson how the company scouts, evaluates, and pursues external innovation; from collaborations to acquisitions. Whether you're a researcher wondering how your work catches industry attention, or simply curious about how Big Pharma thinks, this is a session not to miss.

​The afternoon will include a Q&A and plenty of time to connect with the speaker, fellow participants, and the Nucleate community.

​​

​About the Event Hosts

​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.

​Transfer Center enaCom is the central service unit for all matters related to knowledge and technology transfer at the University of Bonn.